USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: K AND K BIOSCIENCES, INC.
City: LEXINGTON
State: KY
Zip+4: 40502
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (606) 257-4608

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $151,452.00 3
SBIR Phase II $1,511,110.00 2

Award List:

AMINOALKYLPYRIDINES: POTENT ORALLY ACTIVE ANTICONVULSANTS

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Pankaja K Kadaba
Award Amount: $50,000.00

AMINOALKYLPYRIDINES: POTENT ORALLY ACTIVE ANTICONVULSANTS

Award Year / Program / Phase: 1995 / SBIR / Phase II
Agency: HHS
Principal Investigator: Pankaja K Kadaba
Award Amount: $761,182.00
Abstract:
Studies by the applicant on the metabolism and pharmacology of add17014, a novel triazoline anticonvulsant, have led to the discovery of the aminoakylheterocycles as a unique class of anticonvulsant agents. initial work on aminoalkylpyridines indicate they are nontoxic, and highly effective by the… More

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $0.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $749,928.00

1,2,3-TRIAZOLINES: HIGHLY EFFECTIVE ANTIISCHEMIC AGENTS

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Pankaja K. Kadaba
Award Amount: $101,452.00
Abstract:
DESCRIPTION (provided by applicant): There is strong evidence that the 'excitotoxic' action resulting from the excessive accumulation of L-glutamate plays a prominent role in human epilepsy and brain ischemial stroke, leading to neuronal dysfunction and cell death. The… More